Connect
MJA

Volume 164 Issue 10

20 May 1996

Editorials

  • Making fatigue less tiresome John E Murtagh (MJA 1996; 164: 580)
  • Beta-blockers in chronic heart failure: paradox proven? Henry Krum (MJA 1996; 164: 581)
  • Schizophrenia and the community Nicholas A Keks, Tobie Sacks (MJA 1996; 164: 583)

Research

  • Fatigue in selected primary care settings: sociodemographic and psychiatric correlates Ian B Hickie, Ashleigh W Hooker, Dusan Hadzi-Pavlovic, Barbara K Bennett, Andrew J Wilson, Andrew R Lloyd (MJA 1996; 164: 585)
  • Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee Peter McManus, John G Primrose, David A Henry, Donald J Birkett, Julie Lindner, Richard O Day (MJA 1996; 164: 589)
  • Tetanus immunity in an older Australian population Timothy C Heath, Wayne Smith, Anthony G Capon, Mark Hanlon, Paul Mitchell (MJA 1996; 164: 593)

Public Health

  • Iatrogenic and zoonotic Creutzfeldt-Jakob disease: the Australian perspective Steven Collins, Colin L Masters (MJA 1996; 164: 598)
  • Neurosurgery and iatrogenic transmission of Creutzfeld-Jakob disease Raymond L Newcombe (MJA 1996; 164: 603)

Managing HIV

  • Common drug interactions in HIV medicine Dianne L Carey, Richard O Day, Frank J Bowden (MJA 1996; 164: 605)
  • Antiretroviral therapy David Fulcher, Kate Clezy (MJA 1996; 164: 607)
  • HIV and sexually transmitted diseases David C Plummer, Virginia Furner (MJA 1996; 164: 608)
  • HIV and palliative care Paul A Glare, Neil J Cooney (MJA 1996; 164: 612)
  • HIV and autopsies Johan Duflou, Deborah Marriott (MJA 1996; 164: 616)

MJA Practice Essentials - Dermatology

  • The significance of birthmarks Maureen Rogers (MJA 1996; 164: 618)

Clinical Practice

  • The risks and benefits of antithrombotic therapy in chronic atrial fibrillation Graeme J Hankey, Natalie J Gray (MJA 1996; 164: 624)

Medicine and the Community